Evaluation of COPD Co-Pilot

• Conditions: COPD

• Registration Number: NCT03018847
• Lead Sponsor: HGE Health Care Solutions, LLC

Brief Summary

The purpose of undertaking this study is to examine the use of COPD Co-PilotTM, a COPD disease management program manufactured and operated by HGE Health Care Solutions, LLC, in COPD patients outside of the geographic base of HGE's existing patient population (Philadelphia, PA). The purpose is to demonstrate the feasibility of expanding the program to additional geographic sites and to examine whether similar outcome measures are achieved in patients under the supervision of health care providers that are new to the program.

.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01
• Study First Submitted: 2017-01-10
• Study First Submitted QC: 2017-01-10
• Study First Posted: 2017-01-12
• Status Verified: 2018-03
• Primary Completion: 2018-03
• Study Completion: 2018-03
• Last Update Submitted: 2018-03-12
• Last Update Posted: 2018-03-13

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

1. Subject has read, understood and signed an informed consent form prior to enrollment.
2. Males or females age ≥35 years old
3. Documented diagnosis of moderate to very severe COPD (GOLD Level II-IV)
4. Must be able to read and understand English and consent for themselves
5. Subject is willing and able to use an iPad mini device.

Exclusion Criteria

1. Subject has a cognitive impairment (determined by physician) that will make it hard to follow instructions regarding device usage
2. Subject is currently known to suffer from or have a history of significant substance abuse within the last 2 years
3. Subject has any condition that in the opinion of the provider may adversely affect their participation
4. Subject is residing in hospice care, Skilled Nursing Facilities or Long Term Acute Care facilities
5. Subject has a planned procedures at time of enrollment that will occur within timeframe of study that will require hospitalization or otherwise adversely affect their ability to participate
6. Subject has no cellular coverage at their primary residence
7. Subject plans to travel to a location with no cellular coverage for a significant period (>1 week) during their program participation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Adoption	6 months	Percentage of potential daily symptom reports completed by patients

Secondary Outcome Measures

Name	Time	Method
Patient Satisfaction	6 months	patient satisfaction questionnaire
Symptom change detected	6 months	Change index (a numeric value) and the categorical level of change that corresponds to the patient's reported symptoms when compared to their baseline. This is recorded for each daily symptom report submitted after completion of the run-in period.
Clinical responses	6 months	the date, medication or instruction, dosage, frequency, duration of clinical responses sent to subjects, and time elapsed between the patient's check-in and the time the response was acknowledged by the patient.
Medication compliance	6 months	compliance with newly prescribed treatments as reported by patients during follow up phone calls.
Emergency department visits	6 months	emergency department records for period prior to study and during study
Clinic visits	6 months	clinic visits for period prior to study and during study
Medications	6 months	list of medications entered by site coordinator, provider, or reported by subjects to Health Assistants during scheduled monthly phone calls.
Patient reported respiratory symptoms	6 months	Daily values for breathlessness, sputum quantity, sputum color, sputum consistency, peak flow, temperature over 100 F, cough, wheeze, sore throat, and nasal congestion.
Patient profile information	6 months	This will include, among other variables, medial history, smoking history, spirometry results, oxygen use, and diagnoses of co-morbidities.
Source of inpatient admissions and visits to the Emergency Department (ED)	6 months	The source (e.g. from home, from accident, from outpatient clinical, at direction of physician, from ED, etc.) of each and every inpatient admission an emergency department visit will be reported for analyses. These will be reported for the period prior to the enrollment through the study period.
Inpatient Admissions	6 months	admission records for period prior to study and during study
Episode duration	6 months	the date when a mild, moderate or significant level of change is first detected for a patient through the date immediately followed by seven consecutive days in which no level of change is detected. The total number of days in this period, symptoms reported during this period, and clinical responses communicated to the patient (including any treatments or changes) will be reported for analysis.
Hospitalization history	6 months	hospitalization history reported to Health Assistants by patients during scheduled monthly phone calls. This will be reconciled with admissions data from the site and may include utilization at other institutions.
Readmission rate	6 months	The rate and percent of inpatient admissions that occurred within 30, 60, and 90 days of discharge from a prior admission will be reported for analyses. These records will include date of admission, date of discharge, patient name and medical record number, patient DOB, location, length of stay, attending physician, admission diagnosis and diagnosis at discharge. These will be reported for the period prior to the start of the study through the study period.
Length of stay	6 months	total number of inpatient days and the average length of stay per admission will be reported for analyses. These records will include date of admission, date of discharge, patient name and medical record number, patient date of birth (DOB), location, length of stay, attending physician, admission diagnosis and diagnosis at discharge. Reported for period prior to study and during study period
Readmissions	6 months	The number of inpatient admissions that occurred within 30, 60, and 90 days of discharge from a prior admission will be reported for analyses. These records will include date of admission, date of discharge, patient name and medical record number, patient DOB, location, length of stay, attending physician, admission diagnosis, diagnosis at discharge, and associated costs broken down by category. This will be reported for time prior to study and during study period.

Trial Locations

Locations (1)

Medical University of South Carolina; 🇺🇸 Charleston, South Carolina, United States